ENDRA Life Sciences (NDRA) Other Non Operating Income (2016 - 2025)
ENDRA Life Sciences (NDRA) posted quarterly Other Non Operating Income of -$100674.0 for Q4 2025, down 103.35% year-over-year from $3.0 million in Q4 2024, and down 339.6% quarter-over-quarter from $42018.0 in Q3 2025.
ENDRA Life Sciences (NDRA) Other Non Operating Income (2016 - 2025) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Other Non Operating Income for 10 consecutive years, with -$100674.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Other Non Operating Income fell 103.35% year-over-year to -$100674.0; the TTM figure through Dec 2025 stood at $449474.0 (down 85.39% YoY), while the FY2025 annual figure was -$21200.0, down 100.69% from the prior year.
- Other Non Operating Income slipped to -$100674.0 in Q4 2025 per NDRA's latest filing, from $42018.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $3.0 million in Q4 2024 and bottomed at -$100674.0 in Q4 2025.
- Historically, Other Non Operating Income has averaged $232428.2 across 5 years, with a median of $4129.5 in 2023.
- Annual changes were most pronounced in 2022 — Other Non Operating Income tumbled 1883.98% — and 2025, when it soared 8843.44%.
- ENDRA Life Sciences' Other Non Operating Income stood at -$33087.0 in 2021, then soared by 171.89% to $23785.0 in 2022, then surged by 1843.41% to $462241.0 in 2023, then jumped by 550.01% to $3.0 million in 2024, then slumped by 103.35% to -$100674.0 in 2025.
- Business Quant data shows NDRA's Other Non Operating Income at -$100674.0 in Q4 2025, $42018.0 in Q3 2025, and $75178.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | ENDRA Life Sciences | 7.16 Mn | 1.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -100,674.00 |
| Sep 30, 2025 | 42,018.00 |
| Jun 30, 2025 | 75,178.00 |
| Mar 31, 2025 | 432,952.00 |
| Dec 31, 2024 | 5,412.00 |
| Sep 30, 2024 | 3.07 Mn |
| Jun 30, 2024 | 1,700.00 |
| Mar 31, 2024 | 4,841.00 |
| Dec 31, 2023 | 922,726.00 |
| Sep 30, 2023 | -28,226.00 |
| Jun 30, 2023 | 437,433.00 |
| Mar 31, 2023 | 3,418.00 |
| Dec 31, 2022 | 23,785.00 |
| Sep 30, 2022 | -23,011.00 |
| Jun 30, 2022 | -19,374.00 |
| Mar 31, 2022 | -2,933.00 |
| Dec 31, 2021 | -300,142.00 |
| Sep 30, 2021 | -7,507.00 |
| Jun 30, 2021 | 1,086.00 |
| Mar 31, 2021 | 308,600.00 |